Medical News
Stress Hyperglycemia is Predictive of Clinical Outcomes in P...
BMC Neurol.
Stress hyperglycemia, calculated by glucose-to-HbA1c ratio, was independently correlated with worse functional...
28 Jun 2022
Multidrug-Resistant Acinetobacter baumannii May Cause Patien...
Can J Infect Dis Med Microbiol.
Polymicrobial AB-BSI accounted for a significant proportion among all AB-BSI, and it did not influence mortality...
28 Jun 2022
Temporal Trends in Antimicrobial Prescribing During Hospital...
JAMA Intern Med.
In this multihospital cohort study, the time to first antimicrobial for sepsis decreased over time, but this trend...
28 Jun 2022
Usefulness of Fibrosis-4 (FIB-4) Score and Metabolic Alterat...
Int Emerg Med.
Hepatic steatosis had no impact on disease course. The presence of metabolic alterations is associated with severe...
27 Jun 2022
eCMEs
Key Trials
Treatment with Casirivimab and Imdevimab Lowers Hospitalization Rates in High Risk Patients with Mild-to-Moderate COVID-19
The results of this real-world study demonstrated that treatment with casirivimab-imdevimab significantly lowered the rate of hospitalization among...
Casirivimab and Imdevimab Antibody Cocktail Clinically Beneficial in High Risk COVID-19 Patients
Casirivimab and Imdevimab antibody cocktail resulted in lesser requirement of mechanical ventilation and high-flow oxygen with no deaths as compared...
RECOVERY Trial: Efficacy and Safety of Casirivimab and Imdevimab Combination in Hospitalized COVID-19 Patients
RECOVERY Trial evaluated efficacy and safety of casirivimab and imdevimab combination in hospitalized COVID-19 patients. The study showed that in...
REGEN-COV Reduces Risk of Hospitalization and Shortens Time to Resolution of Symptoms in Symptomatic COVID-19 Patients
As per the results of this phase 3, administration of REGEN-COV decreased the risk of Covid-19–related hospitalization or death from any cause....
Slide Library
Cefuroxime (Novacef)
Cefuroxime is a second-generation cephalosporin antibiotic. It is a broad-spectrum antibacterial agent with a favorable pharmacokinetic profile....
Management of Mucormycosis in ENT Practice
Mucormycosis are the group of invasive infection caused by filamentous fungi of the Mucoraceae family. This slide set enumerates prevalence,...
Antifungal Therapy in Immunocompromised Patients
Early initiation of antifungal therapy is a major contributor to enhanced survival rate. This set of slides highlights incidence and risk factors of...
Disseminated Tuberculosis with ARDS
Disseminated TB results from widespread blood borne dissemination of TB bacilli. This presentation includes causes and risk factors of disseminated...
Our Publications
Barijak (Barictinib) Monograph
Barictinib can be useful addition for treatment of Moderate to Severe Covid 19 patients in combination with Remdesivir. Barcitinib inhibits the...
Cipmolnu (Molnupiravir) Monograph
This monograph overviews in-vitro/clinical evidence for Molnupiravir efficacy, safety and positioning.
Molnupiravir: Fact Sheet for Healthcare Givers and Recipients
This fact sheet contains the factual details about the drug molnupiravir, its restricted use under emergency situation, dosage, side effects etc....
Molnupiravir - FAQ Booklet
This document addresses frequently asked questions related to oral antiviral drug Molnupiravir in the treatment of Covid-19.
Poll
Do you perceive any clinical benefits of neurotrophic agent in the management of acute brain injury?
Yes
Sometimes
No
Total votes: 13